Optimal COVID-19 therapeutic candidate discovery using the CANDO platform is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH Office of the Director
Grant: DP1OD006779
NLM NIH HHS
Grant: DP1 LM011509
National Center for Advancing Translational Sciences
Grant: UL1TR001412
NIDA NIH HHS
Grant: K01 DA056690
NLM NIH HHS
Grant: T15 LM012495
National Institutes of Health
Grant: 5DP1OD006779-02
NOVEL PARADIGMS FOR DRUG DISCOVERY: COMPUTATIONAL MULTITARGET SCREENING
National Institutes of Health
Grant: 3UL1TR001412-08S3
Buffalo Clinical and Translational Research Center
National Institutes of Health
Grant: 3T15LM012495-05S1
National Library of Medicine Conference 2022
FWCI
1.46
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals